Leap Therapeutics, Inc. (LPTX)
NASDAQ: LPTX · Real-Time Price · USD
0.2913
-0.0138 (-4.52%)
At close: Apr 1, 2025, 4:00 PM
0.2945
+0.0032 (1.10%)
Pre-market: Apr 2, 2025, 4:20 AM EDT

Leap Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
Apr '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2015
Market Capitalization
1211010645286134
Upgrade
Market Cap Growth
3.96%3.96%137.81%-84.43%113.18%395.35%
Upgrade
Enterprise Value
-354826-3316277
Upgrade
Last Close Price
0.292.884.144.5032.4022.50
Upgrade
PS Ratio
---190.7789.49
Upgrade
PB Ratio
0.323.141.760.762.652.88
Upgrade
P/TBV Ratio
3.143.141.760.762.652.88
Upgrade
EV/Sales Ratio
---107.8051.27
Upgrade
Debt / Equity Ratio
0.010.010.000.010.000.01
Upgrade
Asset Turnover
----0.020.05
Upgrade
Quick Ratio
3.413.415.636.0211.637.07
Upgrade
Current Ratio
3.413.415.656.0511.707.09
Upgrade
Return on Equity (ROE)
-142.43%-142.43%-136.82%-65.48%-52.53%-122.55%
Upgrade
Return on Assets (ROA)
-71.81%-71.81%-75.03%-36.33%-29.17%-57.24%
Upgrade
Return on Capital (ROIC)
-91.49%-91.49%-89.56%-40.73%-32.30%-76.13%
Upgrade
Earnings Yield
-565.99%-61.53%-76.83%-122.52%-14.18%-20.50%
Upgrade
FCF Yield
-501.72%-54.74%-42.60%-110.06%-12.29%-19.34%
Upgrade
Buyback Yield / Dilution
-83.67%-83.67%-80.55%-31.94%-44.66%-162.71%
Upgrade
Updated Mar 26, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q